|
|
|
Info: Your browser does not accept cookies. If you want to put products into your cart and purchase them you need to enable cookies.
Browse
Pharmaceuticals in Japan
Pharmaceuticals in Japan industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry.
The eHealth Market in Japan: Optimizing eHealth Tools
The Internet is becoming a major source of healthcare and treatment information in Japan. In fact, Datamonitor research shows that surveyed consumers in Japan spend the most time online compared to surveyed consumers in the US and Europe. Regional and
PharmaVitae Japanese Comparator Tool
Datamonitor`s PharmaVitae Japanese Comparator Tool builds from the PharmaVitae profiles included in the report `Japanese Pharma to 2010`. This new tool allows you to compare the 15 leading players in this market by current and forecast sales by therap
Japanese Pharma to 2010-Imminent Transition Towards Global
Dominated by domestic companies in the past, the Japanese pharmaceutical market is evolving, as regulatory changes stimulate direct western competition and generic penetration, and government cost containment measures restrict the market. The Japanese
PharmaVitae Japanese Merger Analysis Tool
The Japanese Merger Analysis Tool models the potential outcome of a merger between any of the 15 Japanese pharma companies tracked by PharmaVitae. Users can retain or divest specific products, rationalize forecasts, analyze the resulting company by fo
The Japanese Pharmaceutical Companies Outlook
An analysis of key players and growth strategies evaluates the strengths and weaknesses of the top 10 Japanese pharmaceutical firms` strategic and financial positions, marketed portfolios and pipeline compounds.
Japanese Pharmaceutical Market, 2006-2011
The Japanese pharmaceutical market is the second largest individual market and with sales of $60 billion constitutes approximately 11% of the world market. However, it is a market that frustrates the major pharmaceutical companies as it is growing at
Pricing and Reimbursement in Japan: Costly healthcare system...
The government has relied on simple P&R tools to contain rising healthcare costs and provide a reasonable level of healthcare. However, factors such as a healthier elderly population are masking healthcare system inefficiencies, boosting healthcare co
The Pharmaceutical Company Outlook to 2011
Based on an analysis of 46 companies and 1,000+ products, Datamonitor forecasts that pharmaceutical industry ethical sales will increase at a modest 4.9% CAGR 200511. However, behind this industry average figure there are strategic segments of the ma
Results 1 - 9 of 9
|
|
|
|
